NO20064117L - Kjemisk prosess - Google Patents

Kjemisk prosess

Info

Publication number
NO20064117L
NO20064117L NO20064117A NO20064117A NO20064117L NO 20064117 L NO20064117 L NO 20064117L NO 20064117 A NO20064117 A NO 20064117A NO 20064117 A NO20064117 A NO 20064117A NO 20064117 L NO20064117 L NO 20064117L
Authority
NO
Norway
Prior art keywords
compound
formula
alkyl
approx
chemical process
Prior art date
Application number
NO20064117A
Other languages
English (en)
Norwegian (no)
Inventor
Ulf Larsson
Kajsa Radevik
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20064117L publication Critical patent/NO20064117L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20064117A 2004-03-31 2006-09-13 Kjemisk prosess NO20064117L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0401001A SE0401001D0 (sv) 2004-03-31 2004-03-31 Chemical process
PCT/GB2005/001188 WO2005095358A2 (en) 2004-03-31 2005-03-29 Process for the preparation of aminopyrimidines

Publications (1)

Publication Number Publication Date
NO20064117L true NO20064117L (no) 2006-10-30

Family

ID=32294337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064117A NO20064117L (no) 2004-03-31 2006-09-13 Kjemisk prosess

Country Status (24)

Country Link
US (2) US7799914B2 (ja)
EP (2) EP2308853A1 (ja)
JP (1) JP5059599B2 (ja)
KR (1) KR101164265B1 (ja)
CN (2) CN1938284B (ja)
AT (1) ATE517096T1 (ja)
AU (1) AU2005227727B2 (ja)
BR (1) BRPI0509323A (ja)
CA (1) CA2560094C (ja)
CY (1) CY1111847T1 (ja)
DK (1) DK1751117T3 (ja)
ES (1) ES2368069T3 (ja)
HK (1) HK1103727A1 (ja)
HR (1) HRP20110658T1 (ja)
IL (1) IL177998A (ja)
NO (1) NO20064117L (ja)
NZ (2) NZ550128A (ja)
PL (1) PL1751117T3 (ja)
PT (1) PT1751117E (ja)
SE (1) SE0401001D0 (ja)
SG (1) SG151311A1 (ja)
SI (1) SI1751117T1 (ja)
WO (1) WO2005095358A2 (ja)
ZA (1) ZA200607708B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401001D0 (sv) * 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process
PT1987012E (pt) * 2006-02-13 2010-07-16 Lonza Ag Reduã†o de 5-(arildiazenil)-4,6-di-halopirimidina
SG196805A1 (en) 2008-09-09 2014-02-13 Astrazeneca Ab A process for preparing [1s- [1-alpha, 2-alpha, 3-beta (1s*, 2r*) 5-beta] ] -3- [7- [2- (3, 4-dif luorophenyl) -cyclopropylamino] - 5- (propylthio) -3h-1, 2, 3-triazolo [4, 5-d] pyrimidin-3-yl] -5- (2- hydroxyethoxy) cyclopentane-1, 2-diol and to its intermediates
EP2305376A1 (en) * 2009-09-23 2011-04-06 Lonza Ltd. Process and catalyst for the catalytic hydrogenation of aromatic and heteroaromatic nitro compounds
US9233966B2 (en) 2012-04-05 2016-01-12 Dr. Reddy's Laboratories Limited Preparation of ticagrelor
CN103130726A (zh) * 2013-02-07 2013-06-05 许学农 替卡格雷中间体4,6-二氯-2-(丙巯基)-5-氨基嘧啶的制备方法
WO2014206187A1 (zh) 2013-06-24 2014-12-31 苏州明锐医药科技有限公司 替卡格雷及其中间体的制备方法
EP3036227B1 (en) 2013-08-22 2020-01-08 Genentech, Inc. Process for preparing a compound
CN103588712B (zh) * 2013-11-08 2016-06-08 南京欧信医药技术有限公司 一种嘧啶类化合物及其制备方法、和应用
CN103923020A (zh) * 2014-04-02 2014-07-16 黄河三角洲京博化工研究院有限公司 一种2-丙硫基-4,6-二氯-5-氨基嘧啶的制备方法
CN105020602B (zh) * 2014-04-30 2017-12-08 欧普照明股份有限公司 一种led灯
CN103992277A (zh) * 2014-05-16 2014-08-20 苏州天马精细化学品股份有限公司 一种替卡格雷中间体4,6-二氯-5-氨基-2-丙硫基嘧啶的制备方法
CN105294573B (zh) * 2015-06-16 2018-07-10 厦门医学院 一种合成4,6-二氯-2-(丙硫基)-5-氨基嘧啶的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL297372A1 (en) * 1991-04-06 1993-09-06 Fisons Plc Atp analogs
ATE198471T1 (de) 1995-05-19 2001-01-15 Novartis Erfind Verwalt Gmbh Verfahren zur katalytischen hydrogenierung von aromatischen nitroverbindungen
TW530058B (en) 1997-07-22 2003-05-01 Astra Pharma Prod Triazolo [4,5-d]pyrimidine compounos and their use and process for preparation
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013488D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Chemical compound
US6818720B2 (en) * 2001-11-08 2004-11-16 Degussa Ag Supported hydrogenating catalyst in powder form
SE0401001D0 (sv) * 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process

Also Published As

Publication number Publication date
SE0401001D0 (sv) 2004-03-31
JP2007530650A (ja) 2007-11-01
CN1938284B (zh) 2010-08-11
WO2005095358A3 (en) 2006-01-05
NZ587999A (en) 2012-04-27
IL177998A (en) 2012-03-29
BRPI0509323A (pt) 2007-09-04
CA2560094A1 (en) 2005-10-13
US20070219371A1 (en) 2007-09-20
CN1938284A (zh) 2007-03-28
KR101164265B1 (ko) 2012-07-09
CY1111847T1 (el) 2015-10-07
ZA200607708B (en) 2008-06-25
HRP20110658T1 (hr) 2011-10-31
PL1751117T3 (pl) 2011-11-30
EP1751117B1 (en) 2011-07-20
NZ550128A (en) 2010-10-29
SI1751117T1 (sl) 2011-10-28
CN101851212A (zh) 2010-10-06
HK1103727A1 (en) 2007-12-28
PT1751117E (pt) 2011-09-19
WO2005095358A2 (en) 2005-10-13
KR20060133019A (ko) 2006-12-22
EP1751117A2 (en) 2007-02-14
AU2005227727B2 (en) 2009-03-26
ATE517096T1 (de) 2011-08-15
US20100324289A1 (en) 2010-12-23
EP2308853A1 (en) 2011-04-13
DK1751117T3 (da) 2011-10-10
SG151311A1 (en) 2009-04-30
JP5059599B2 (ja) 2012-10-24
AU2005227727A1 (en) 2005-10-13
IL177998A0 (en) 2006-12-31
ES2368069T3 (es) 2011-11-14
US7799914B2 (en) 2010-09-21
CA2560094C (en) 2012-10-30

Similar Documents

Publication Publication Date Title
NO20064117L (no) Kjemisk prosess
RU2009133453A (ru) Фторсодержащее пиразолкарбонитрильное производное и способ его получения и фторсодержащее производное пиразолкарбоновой кислоты, полученное с применением фторсодержащего пиразолкарбонитрильного производного и способ его получения
PE20061450A1 (es) Proceso para la preparacion de derivados de sulfamida
EA201390916A1 (ru) Новые ферроценовые метки для электрохимического анализа и их применение в аналитических способах
RU2011133749A (ru) Способ получения и выделения 2-ациламино-3-дифенилпропионовой кислоты
RU2009113019A (ru) Способы получения 1,2,4-оксадиазолбензойных кислот
HRP20080618T3 (en) Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
HK1096973A1 (en) Exemestane and its intermediates and methods of making the same
DE502006008710D1 (de) Substituierte tetrahydroisochinoline als mmp-inhibitoren, verfahren zu ihrer herstellung und ihre verwendung als medikament
CO6231030A2 (es) Metodos para preparar compuestos basados en imidazol como potentes inhibidores de respuesta inmune
NO20075618L (no) Novel compounds as GLP-1 Agonists
DK1442006T3 (da) Fremstilling af amfetaminer fra phenylpropanolaminer
UA89218C2 (ru) Способ получения галогенбензолов (варианты)
RU2011144572A (ru) Стабильная при низких температурах биоцидная композиция
TW200619201A (en) Process for the preparation of pyrazoles
DE602006001394D1 (de) Verfahren zur herstellung einer vorstufe von vitamin b1
AR059375A1 (es) Procedimiento para produccion de 5-alcoxi-4-hidroximetilpirazol y compuestos
PE20081342A1 (es) Derivados eter como moduladores duales de los receptores de 5-ht2a y d3
EA200800633A1 (ru) Способ получения производных сартана и промежуточных соединений, пригодных для этого способа
DE602006005230D1 (de) Verfahren zur herstellung von 2-azabicycloä3.3.0üoctan-3-carbonsäurederivaten
ECSP088115A (es) Procedimiento para la preparación de compuestos de 1-[ciano(4-hidroxifenil)metil]ciclohexanol
RU2008106461A (ru) Способы получения производных пиразол-о-гликозида и новых промежуточных соединений для применения в указанных способах
NO20083025L (no) Fremgangsmate for fremstilling av 2-kloretoksy-eddiksyre-N,N-dimetylamid
DE602007002486D1 (de) Verfahren zur herstellung von 1-halogen-2,7-naphthyridinylderivaten
RU2008142736A (ru) Способ получения производных этилендиамина, имеющих карбаматную группу и ациальную группу, и промежуточных веществ для получения производных

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application